|
FADS1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.917400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.765600E-01 |
| Normal-vs-Stage2 |
3.693800E-01 |
| Normal-vs-Stage3 |
1.539820E-01 |
| Normal-vs-Stage4 |
1.682820E-01 |
| Stage1-vs-Stage2 |
4.618800E-01 |
| Stage1-vs-Stage3 |
1.655200E-01 |
| Stage1-vs-Stage4 |
2.044400E-01 |
| Stage2-vs-Stage3 |
9.664400E-01 |
| Stage2-vs-Stage4 |
8.138600E-01 |
| Stage3-vs-Stage4 |
7.872000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.462440E-01 |
| Normal-vs-AfricanAmerican |
1.173150E-01 |
| Normal-vs-Asian |
1.020790E-01 |
| Caucasian-vs-AfricanAmerican |
2.641400E-01 |
| Caucasian-vs-Asian |
8.358100E-04 |
| AfricanAmerican-vs-Asian |
1.409920E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.861600E-02 |
| Normal-vs-Female |
6.483400E-01 |
| Male-vs-Female |
4.184100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.157800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.080200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.252300E-02 |
| Normal-vs-Age(81-100Yrs) |
1.715750E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.371400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.180000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.858200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.450000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.051580E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.740000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.663000E-01 |
| Classical-VS-Follicular |
1.112580E-01 |
| Classical-VS-Other |
5.248200E-01 |
| Classical-VS-Normal |
1.273360E-01 |
| Tall-VS-Follicular |
4.593000E-01 |
| Tall-VS-Other |
6.004200E-01 |
| Tall-VS-Normal |
4.771600E-01 |
| Follicular-VS-Other |
9.228000E-01 |
| Follicular-VS-Normal |
9.772800E-01 |
| Other-VS-Normal |
8.930000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.521800E-01 |
| Normal-vs-N1 |
6.083000E-01 |
| N0-vs-N1 |
9.424200E-01 |
|
|
